Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 9-England to go back into COVID-19 lockdown from midnight - BBC

Mon, 04th Jan 2021 07:57

* PM Johnson set to announce tougher restrictions

* New measures likely to come into force from midnight - BBC

* UK first to roll out AstraZeneca vaccine

* 82-year-old dialysis patient is first to get shot

* UK hails British scientific 'triumph'

* Concerns grow over South African variant
(Recasts with BBC report)

By William Schomberg, Alistair Smout and Guy Faulconbridge

LONDON, Jan 4 (Reuters) - British Prime Minister Boris
Johnson is set to announce later on Monday a new coronavirus
lockdown for all of England similar to the one imposed when the
pandemic hit the country in March, the BBC reported.

The measures would include school closures for most pupils
and people would be asked to work from home unless they are
unable to do their jobs remotely or are key workers, the BBC
said, adding the measures would come into effect from midnight.

Johnson is due to deliver a televised address to the nation
at 2000 GMT.

Earlier on Monday, his government touted a scientific
"triumph" as Britain became the first country in the world to
start vaccinating its population with Oxford University and
AstraZeneca's COVID-19 shot.

Dialysis patient Brian Pinker, 82, received the first
Oxford/AstraZeneca shot outside of a trial.

"I am so pleased to be getting the COVID vaccine today and
really proud that it is one that was invented in Oxford," said
Pinker, a retired maintenance manager, just a few hundred metres
from where the vaccine was developed.

Britain is grappling with the world's sixth highest death
toll and one of the worst economic hits from the COVID-19
crisis. More than 75,000 people in the United Kingdom have died
from COVID-19 within 28 days of a positive test.

It was the first country to roll out the vaccine developed
by Pfizer and Germany's BioNTech almost a
month ago, and is prioritising getting a first dose of vaccines
to as many people as possible over giving second doses.

Some experts say they are worried about such an approach.

Two new variants of the coronavirus are complicating the
COVID-19 response and Britain has seen a resurgence in cases to
new daily highs.

UK scientists have expressed concern that the vaccines being
rolled out may not be able to protect against a new variant of
the coronavirus that emerged in South Africa and has spread
internationally.

Britain's parliament will be recalled on Wednesday to debate
the lockdown measures.

Moving ahead of Johnson, Scottish First Minister Nicola
Sturgeon earlier on Monday imposed the most stringent lockdown
for Scotland since last spring.
(Additional reporting by Elizabeth Piper, Writing by William
James, Guy Faulconbridge and Alistair Smout; Editing by Kate
Holton, Nick Macfie, Mike Collett-White and Gareth Jones)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.